Parallel Advisors’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$19.4M Sell
104,614
-2,428
-2% -$451K 0.39% 42
2025
Q1
$22.4M Sell
107,042
-1,143
-1% -$239K 0.51% 30
2024
Q4
$19.2M Sell
108,185
-620
-0.6% -$110K 0.43% 41
2024
Q3
$21.5M Sell
108,805
-1,302
-1% -$257K 0.51% 28
2024
Q2
$18.9M Sell
110,107
-1,340
-1% -$230K 0.48% 32
2024
Q1
$20.3M Buy
111,447
+1,043
+0.9% +$190K 0.55% 25
2023
Q4
$17.1M Sell
110,404
-1,755
-2% -$272K 0.51% 36
2023
Q3
$16.7M Buy
112,159
+1,659
+2% +$247K 0.56% 34
2023
Q2
$14.9M Sell
110,500
-1,315
-1% -$177K 0.48% 43
2023
Q1
$17.8M Buy
111,815
+75,111
+205% +$12M 0.6% 30
2022
Q4
$5.93M Buy
36,704
+3,307
+10% +$534K 0.26% 64
2022
Q3
$4.48M Buy
33,397
+2,537
+8% +$340K 0.21% 79
2022
Q2
$4.73M Sell
30,860
-420
-1% -$64.3K 0.22% 74
2022
Q1
$5.12M Sell
31,280
-322
-1% -$52.7K 0.2% 80
2021
Q4
$4.28M Buy
31,602
+3,263
+12% +$442K 0.16% 102
2021
Q3
$3.06M Buy
28,339
+187
+0.7% +$20.2K 0.12% 123
2021
Q2
$3.17M Buy
28,152
+3,137
+13% +$353K 0.13% 114
2021
Q1
$2.71M Buy
25,015
+1,287
+5% +$139K 0.13% 118
2020
Q4
$2.54M Sell
23,728
-1,549
-6% -$166K 0.14% 114
2020
Q3
$2.21M Buy
25,277
+805
+3% +$70.5K 0.14% 125
2020
Q2
$2.4M Buy
24,472
+1,827
+8% +$179K 0.16% 101
2020
Q1
$1.73M Buy
22,645
+13
+0.1% +$990 0.14% 112
2019
Q4
$2M Buy
22,632
+97
+0.4% +$8.59K 0.15% 117
2019
Q3
$1.71M Sell
22,535
-6,381
-22% -$483K 0.15% 119
2019
Q2
$2.1M Buy
28,916
+3,167
+12% +$230K 0.21% 88
2019
Q1
$2.08M Sell
25,749
-441
-2% -$35.5K 0.23% 84
2018
Q4
$2.41M Buy
26,190
+736
+3% +$67.8K 0.34% 56
2018
Q3
$2.41M Buy
25,454
+4,369
+21% +$413K 0.3% 62
2018
Q2
$1.95M Buy
21,085
+4,623
+28% +$428K 0.28% 62
2018
Q1
$1.56M Buy
16,462
+153
+0.9% +$14.5K 0.24% 78
2017
Q4
$1.58M Sell
16,309
-376
-2% -$36.4K 0.26% 73
2017
Q3
$1.59M Sell
16,685
-392
-2% -$37.3K 0.27% 69
2017
Q2
$1.19M Buy
17,077
+264
+2% +$18.5K 0.23% 88
2017
Q1
$1.12M Buy
16,813
+2,220
+15% +$148K 0.22% 88
2016
Q4
$914K Buy
+14,593
New +$914K 0.21% 83